Developer docs
API playgroundTry for free, no card

Search company profiles

Al Ittihad Drug Store

Full company profile

uuid000fuse

Namestring
Al Ittihad Drug Store
Legal namestring
Al Ittihad Drug Store
Websiteurl
ids.ae
Company typeenum
Private
Founded yearint
1987
Descriptiontext

Al Ittihad Drug Store (IDS) is a Dubai-headquartered, B2B pharmaceutical and consumer healthcare distributor serving the United Arab Emirates. Founded in 1987, the company operates a comprehensive distribution network reaching 99% of UAE pharmacies and 100% of government and private hospitals, executing 70,000+ deliveries per year within a 12-24 hour on-time window. It distributes products for 40+ global pharmaceutical and consumer health partners, including Bayer, Novartis, Sanofi, GlaxoSmithKline, Sandoz, Aurobindo, Acino, Alfasigma, and Merz, providing these principals with end-to-end market access support in the UAE.

IDS organizes its offering into six service modules: Regulatory Affairs & Pharmacovigilance (approvals, compliance, market access), Advanced Pharma Logistics (supply chain operations), Sales & Marketing (commercial execution), Institutional & Market Access (penetration of government and private accounts), Digital & Operational Excellence (process and digital optimization), and Distribution & Supply Chain (last-mile delivery). The platform combines regulatory expertise, distribution scale, and commercial execution to act as the UAE entry and growth vehicle for global healthcare principals.

Al Ittihad Drug Store is a wholly-owned subsidiary of Mubadala Bio, the life-sciences arm of Mubadala Investment Company, having transitioned from 80% Mubadala ownership in December 2024 to full ownership in February 2026, alongside the related Global Medical Supply Chain (GMSC) entity under the Pharma Logistics vertical. Its revenue model combines transaction-based pharmaceutical distribution with professional-services revenue from regulatory affairs, pharmacovigilance, and market access engagements; pricing is quote-based and not publicly disclosed. The customer base spans three primary segments — government hospitals, private hospitals, and retail pharmacies — with global healthcare companies functioning as both principals and channel partners.

Short descriptiontext

Al Ittihad Drug Store (IDS) is a UAE-based B2B pharmaceutical and consumer healthcare distributor serving government hospitals, private hospitals, and retail pharmacies, with 99% UAE coverage and 40+ global principals. IDS is a wholly-owned Mubadala Bio subsidiary operating under the Pharma Logistics vertical.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersDubai, United Arab Emirates
HQ citystring
Dubai
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical distribution, healthcare logistics, market access services, regulatory affairs, consumer healthcare supply
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Pharmaceutical Distribution
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Pharmaceutical Distribution
TypeTransaction Fee
Description

Revenue generated from distributing pharmaceutical and consumer healthcare products to government and private hospitals and pharmacies across the UAE

ids.ae
2Market Access Services
TypeProfessional Services
Description

Commercial execution and market access support services for global healthcare companies entering the UAE market

ids.ae
3Regulatory Services
TypeProfessional Services
Description

Regulatory affairs and pharmacovigilance support services

ids.ae
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Al Ittihad Drug Store (IDS) is a UAE-based B2B distributor and market access partner for pharmaceutical and consumer healthcare products. It provides end-to-end distribution to government hospitals, private hospitals, and 99% of pharmacies in the UAE, supported by regulatory affairs, pharmacovigilance, sales and marketing execution, and advanced pharma logistics capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 70,000+ deliveries annually
+4 more records
Product overview1 text field

Al Ittihad Drug Store (IDS) operates as a unified healthcare distribution platform under Mubadala Bio's Pharma Logistics vertical, offering an integrated suite of six interconnected service modules. The platform combines Regulatory Affairs & Pharmacovigilance for compliance navigation, Advanced Pharma Logistics for supply chain operations, Sales & Marketing for commercial execution, Institutional & Market Access for market penetration, Digital & Operational Excellence for efficiency optimization, and Distribution & Supply Chain for last-mile delivery. Founded in 1987 and now part of Mubadala Bio following full acquisition in 2026, IDS serves as a healthcare distribution and market access partner supporting the full lifecycle of pharmaceutical and consumer healthcare products in the UAE market.

Product and service1 record
1Pharmaceutical Distribution & Supply Chain
CategoryPharmaceutical Distribution
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership12 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-05-12
Description

IDS signed an exclusive distribution agreement with L-Nutra to expand access to longevity-focused nutrition solutions in the UAE. This partnership strengthens IDS's portfolio in the consumer healthcare segment.

2GlobalOne Healthcare Holding (GHH)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Previous parent company from which Mubadala acquired the 80% stake in December 2024. GHH retained 20% stake following initial acquisition.

ids.ae
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

7Sandoz
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

ids.ae
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Affiliated company under Mubadala Bio; acquired alongside IDS as part of Mubadala's healthcare logistics vertical integration strategy

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

11Alfasigma
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

ids.ae
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Pharmaceutical partner displayed in IDS partner logos section

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GMSC is the sister company of IDS under Mubadala Bio's Pharma Logistics vertical, also acquired in 2024–2026. It operates in adjacent healthcare logistics and distribution in the UAE, making it the most directly comparable peer.

2Julphar (Gulf Pharmaceutical Industries)
TypeRegional player
Description

Julphar is one of the largest pharmaceutical manufacturers based in the UAE with regional GCC distribution reach. While primarily a manufacturer, it competes for shelf space and institutional contracts that IDS distributes, making it a relevant regional comparable.

TypeRegional player
Description

SPIMACO is a leading Saudi pharmaceutical manufacturer and distributor serving the GCC. Its regional distribution footprint across Saudi Arabia and adjacent markets makes it a geographic peer, though it is Saudi-domiciled rather than UAE.

TypeBroad incumbent
Description

Hikma is a multinational pharmaceutical company with significant MENA manufacturing and distribution operations. As a broader incumbent in regional pharma supply, it competes for similar institutional customers and represents the larger-scale player IDS benchmarks against.

TypeRegional player
Description

Tabuk is a major Saudi-based pharmaceutical manufacturer with growing GCC presence. It is comparable as a regional pharma player whose products flow through similar hospital and pharmacy channels in the GCC.

TypeBroad incumbent
Description

Aster DM Healthcare operates a large network of pharmacies, clinics and hospitals across the GCC and India. Its pharmacy retail and pharmaceutical distribution operations in the UAE overlap directly with IDS's downstream pharmacy channels.

TypeRegional player
Description

Dallah Healthcare is a Saudi healthcare conglomerate operating hospitals, clinics and pharmaceutical distribution. It serves a comparable role as a regional, integrated healthcare distribution and services platform — though primarily in Saudi Arabia.

8McKesson Corporation
TypeBroad incumbent
Description

McKesson is one of the world's largest pharmaceutical wholesalers and distributors. While operating at vastly different scale and geography, it represents the global best-practice benchmark for the distribution model IDS executes in the UAE.

TypeBroad incumbent
Description

Cencora is a global pharmaceutical distribution and solutions company serving manufacturers and healthcare providers. As a broad incumbent in pharma distribution, it defines the global operational and commercial benchmarks for companies like IDS.

TypeEmerging player
Description

BinSina is a UAE pharmacy retail chain that is a downstream customer of pharmaceutical distributors like IDS. It is comparable as an emerging player in UAE pharmacy distribution and retail, sitting on the buy-side of IDS's value chain.

Market position
Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Al Ittihad Drug Store

Pharmaceutical Distributionids.ae

Al Ittihad Drug Store (IDS) is a UAE-based B2B pharmaceutical and consumer healthcare distributor serving government hospitals, private hospitals, and retail pharmacies, with 99% UAE coverage and 40+ global principals. IDS is a wholly-owned Mubadala Bio subsidiary operating under the Pharma Logistics vertical.

What Al Ittihad Drug Store does

Al Ittihad Drug Store (IDS) is a Dubai-headquartered, B2B pharmaceutical and consumer healthcare distributor serving the United Arab Emirates. Founded in 1987, the company operates a comprehensive distribution network reaching 99% of UAE pharmacies and 100% of government and private hospitals, executing 70,000+ deliveries per year within a 12-24 hour on-time window. It distributes products for 40+ global pharmaceutical and consumer health partners, including Bayer, Novartis, Sanofi, GlaxoSmithKline, Sandoz, Aurobindo, Acino, Alfasigma, and Merz, providing these principals with end-to-end market access support in the UAE.

IDS organizes its offering into six service modules: Regulatory Affairs & Pharmacovigilance (approvals, compliance, market access), Advanced Pharma Logistics (supply chain operations), Sales & Marketing (commercial execution), Institutional & Market Access (penetration of government and private accounts), Digital & Operational Excellence (process and digital optimization), and Distribution & Supply Chain (last-mile delivery). The platform combines regulatory expertise, distribution scale, and commercial execution to act as the UAE entry and growth vehicle for global healthcare principals.

Al Ittihad Drug Store is a wholly-owned subsidiary of Mubadala Bio, the life-sciences arm of Mubadala Investment Company, having transitioned from 80% Mubadala ownership in December 2024 to full ownership in February 2026, alongside the related Global Medical Supply Chain (GMSC) entity under the Pharma Logistics vertical. Its revenue model combines transaction-based pharmaceutical distribution with professional-services revenue from regulatory affairs, pharmacovigilance, and market access engagements; pricing is quote-based and not publicly disclosed. The customer base spans three primary segments — government hospitals, private hospitals, and retail pharmacies — with global healthcare companies functioning as both principals and channel partners.

Al Ittihad Drug Store firmographics

Firmographics
Name
Al Ittihad Drug Store
Legal name
Al Ittihad Drug Store
Website
https://ids.ae
Company type
Private
Founded year
1987
Operating status
Operating
Headcount range
101–250 employees
Short description
Al Ittihad Drug Store (IDS) is a UAE-based B2B pharmaceutical and consumer healthcare distributor serving government hospitals, private hospitals, and retail pharmacies, with 99% UAE coverage and 40+ global principals. IDS is a wholly-owned Mubadala Bio subsidiary operating under the Pharma Logistics vertical.
Ownership category
akta.pro rank

Where Al Ittihad Drug Store is headquartered

Location

Headquarters

HQ city
Dubai
HQ country
United Arab Emirates
HQ region
Middle East

Offices1 record

Markets served

Al Ittihad Drug Store business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Supply Chain, Infrastructure, Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Pharmaceutical Distribution: Revenue generated from distributing pharmaceutical and consumer healthcare products to government and private hospitals and pharmacies across the UAE
  2. Market Access Services: Commercial execution and market access support services for global healthcare companies entering the UAE market
  3. Regulatory Services: Regulatory affairs and pharmacovigilance support services

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Al Ittihad Drug Store product offering

Product offering

Core offering

Al Ittihad Drug Store (IDS) is a UAE-based B2B distributor and market access partner for pharmaceutical and consumer healthcare products. It provides end-to-end distribution to government hospitals, private hospitals, and 99% of pharmacies in the UAE, supported by regulatory affairs, pharmacovigilance, sales and marketing execution, and advanced pharma logistics capabilities.

Product overview

Al Ittihad Drug Store (IDS) operates as a unified healthcare distribution platform under Mubadala Bio's Pharma Logistics vertical, offering an integrated suite of six interconnected service modules. The platform combines Regulatory Affairs & Pharmacovigilance for compliance navigation, Advanced Pharma Logistics for supply chain operations, Sales & Marketing for commercial execution, Institutional & Market Access for market penetration, Digital & Operational Excellence for efficiency optimization, and Distribution & Supply Chain for last-mile delivery. Founded in 1987 and now part of Mubadala Bio following full acquisition in 2026, IDS serves as a healthcare distribution and market access partner supporting the full lifecycle of pharmaceutical and consumer healthcare products in the UAE market.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Distribution & Supply Chain

Quantifiable outcome

  • 70,000+ deliveries annually
  • +4 more outcomes

Companies that use Al Ittihad Drug Store

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Al Ittihad Drug Store technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Al Ittihad Drug Store partnerships and signals

Strategic signal

Partnerships

Twelve partnerships are on record, tiered core and minor.

  • L-NutracoreChannel Partner/ Reseller/ Distributor · 12 May 2026IDS signed an exclusive distribution agreement with L-Nutra to expand access to longevity-focused nutrition solutions in the UAE. This partnership strengthens IDS's portfolio in the consumer healthcare segment.
  • GlobalOne Healthcare Holding (GHH)minorStrategic or Co-development PartnerPrevious parent company from which Mubadala acquired the 80% stake in December 2024. GHH retained 20% stake following initial acquisition.
  • BayercoreChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • NovartiscoreChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • SanoficoreChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • GlaxoSmithKline (GSK)coreChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • SandozcoreChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • Global Medical Supply Chain (GMSC)coreStrategic or Co-development PartnerAffiliated company under Mubadala Bio; acquired alongside IDS as part of Mubadala's healthcare logistics vertical integration strategy
  • AurobindominorChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • AcinominorChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • AlfasigmaminorChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section
  • MerzminorChannel Partner/ Reseller/ DistributorPharmaceutical partner displayed in IDS partner logos section

Scale indicators5 records

Recent moves4 records

Expansion highlights4 records

Al Ittihad Drug Store competitors and assessment

Company assessment

Direct peers

  • Global Medical Supply Chain (GMSC): GMSC is the sister company of IDS under Mubadala Bio's Pharma Logistics vertical, also acquired in 2024–2026. It operates in adjacent healthcare logistics and distribution in the UAE, making it the most directly comparable peer.

Regional players

  • Julphar (Gulf Pharmaceutical Industries): Julphar is one of the largest pharmaceutical manufacturers based in the UAE with regional GCC distribution reach. While primarily a manufacturer, it competes for shelf space and institutional contracts that IDS distributes, making it a relevant regional comparable.
  • SPIMACO Addwaa: SPIMACO is a leading Saudi pharmaceutical manufacturer and distributor serving the GCC. Its regional distribution footprint across Saudi Arabia and adjacent markets makes it a geographic peer, though it is Saudi-domiciled rather than UAE.
  • Tabuk Pharmaceuticals: Tabuk is a major Saudi-based pharmaceutical manufacturer with growing GCC presence. It is comparable as a regional pharma player whose products flow through similar hospital and pharmacy channels in the GCC.
  • Dallah Healthcare Holding: Dallah Healthcare is a Saudi healthcare conglomerate operating hospitals, clinics and pharmaceutical distribution. It serves a comparable role as a regional, integrated healthcare distribution and services platform — though primarily in Saudi Arabia.

Broad incumbents

  • Hikma Pharmaceuticals: Hikma is a multinational pharmaceutical company with significant MENA manufacturing and distribution operations. As a broader incumbent in regional pharma supply, it competes for similar institutional customers and represents the larger-scale player IDS benchmarks against.
  • Aster DM Healthcare: Aster DM Healthcare operates a large network of pharmacies, clinics and hospitals across the GCC and India. Its pharmacy retail and pharmaceutical distribution operations in the UAE overlap directly with IDS's downstream pharmacy channels.
  • McKesson Corporation: McKesson is one of the world's largest pharmaceutical wholesalers and distributors. While operating at vastly different scale and geography, it represents the global best-practice benchmark for the distribution model IDS executes in the UAE.
  • Cencora (formerly AmerisourceBergen): Cencora is a global pharmaceutical distribution and solutions company serving manufacturers and healthcare providers. As a broad incumbent in pharma distribution, it defines the global operational and commercial benchmarks for companies like IDS.

Emerging players

  • BinSina Pharmacy: BinSina is a UAE pharmacy retail chain that is a downstream customer of pharmaceutical distributors like IDS. It is comparable as an emerging player in UAE pharmacy distribution and retail, sitting on the buy-side of IDS's value chain.

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Al Ittihad Drug Store social profiles

Digital presence

Al Ittihad Drug Store compliance and trust

Trust signal

Compliance3 records

Al Ittihad Drug Store financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Al Ittihad Drug Store leadership team

Management profile

Number of profiles

Al Ittihad Drug Store funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Al Ittihad Drug Store M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Al Ittihad Drug Store

What does Al Ittihad Drug Store do?

Al Ittihad Drug Store (IDS) is a UAE-based B2B distributor and market access partner for pharmaceutical and consumer healthcare products. It provides end-to-end distribution to government hospitals, private hospitals, and 99% of pharmacies in the UAE, supported by regulatory affairs, pharmacovigilance, sales and marketing execution, and advanced pharma logistics capabilities.

Is Al Ittihad Drug Store a public or private company?

Al Ittihad Drug Store is a private company. It is classified as corporate owned and is currently operating.

When was Al Ittihad Drug Store founded?

Al Ittihad Drug Store was founded in 1987. It employs 101 to 250 people.

Where is Al Ittihad Drug Store based?

Al Ittihad Drug Store is headquartered in Dubai, United Arab Emirates, in the Middle East region.

How does Al Ittihad Drug Store make money?

Three revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are market Access Services and regulatory Services.

Who are Al Ittihad Drug Store's main competitors?

Global Medical Supply Chain (GMSC) is listed as a direct peer. Regional players are Julphar (Gulf Pharmaceutical Industries), SPIMACO Addwaa, Tabuk Pharmaceuticals and Dallah Healthcare Holding. Broad incumbents are Hikma Pharmaceuticals, Aster DM Healthcare, McKesson Corporation and Cencora (formerly AmerisourceBergen). BinSina Pharmacy is listed as an emerging player.

Does Al Ittihad Drug Store have an API?

No public API is recorded for Al Ittihad Drug Store.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ZawyaMubadala Bio unveils new brand identities for IDS and GMSCMubadala Bio announced new brand identities for Al Ittihad Drug Store (IDS) and Global Medical Supply Chain (GMSC) to reflect their expanded strategic role in life sciences. The rebrand follows full acquisition earlier this year, with IDS signing agreements with L-Nutra, Valeo Health, Bayer, and Globalpharma, and GMSC opening a 2,500 sqm warehouse in KEZAD.ZawyaGlobalpharma signs 7 strategic MoUs advancing R&D, manufacturing and sustainabilityGlobalpharma signed seven strategic MoUs with partners to advance R&D, manufacturing, and sustainability. The collaborations include ZIM Laboratories, Masibus, Rockwell Automation, and 386 Sky Solar, with a 612 kWp rooftop PV plant expected to generate 25.3 GWh and avoid 11,400 tonnes of CO₂ emissions.ZawyaMubadala Bio’s IDS and Bayer renew partnership to expand access to key therapies across the UAEMubadala Bio's IDS and Bayer renewed their partnership to expand access to healthcare products across the UAE. The agreement, signed by Hamad Husein Almarzooqi and Uwe Dalichow, aims to strengthen supply chain resilience and ensure patients benefit from high-quality solutions. IDS mobilized a dedicated team to support the expanded scope.ZawyaMubadala Bio’s IDS signs agreement with Valeo Health to launch online channel for consumer health productsMubadala Bio's IDS signed an agreement with Valeo Health to launch an online channel for consumer health products, strengthening its digital distribution and direct-to-consumer strategy. Valeo Health will serve as the exclusive online partner, making existing longevity and wellness products more widely available across the GCC.YahooMubadala buys majority stakes in two UAE healthcare firmsMubadala Investment Company acquired 80% stakes in Global Medical Supply Chain and Al Ittihad Drug Store from GlobalOne Healthcare Holding, which retains 20% in each. The firms serve over 200 UAE medical facilities and distribute over 1,000 products. The move supports Mubadala's vertically integrated life sciences strategy.The NationalMubadala acquires 80% stake in Global Medical Supply Chain and Al Ittihad Drug StoreMubadala Investment Company acquired an 80% stake in Global Medical Supply Chain and Al Ittihad Drug Store from GlobalOne Healthcare Holding, retaining a 20% stake. The deal expands Mubadala's healthcare logistics and pharmaceutical distribution footprint, with GMSC serving over 200 medical facilities and IDS distributing over 1,000 products.